Adalimumab/infliximabPsoriasiform lesions: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1416卷 / 1期

关键词：

Methotrexate; Inflammatory Bowel Disease; Psoriasis; Ulcerative Colitis; Infliximab;

D O I：

10.2165/00128415-201214160-00020

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：7 / 7

相关论文

共 50 条

[1] Adalimumab/infliximabPsoriasiform skin lesions: case report
Reactions Weekly, 2016, 1597 (1) : 14 - 14
[2] Adalimumab/etanercept/infliximabPsoriasiform eruptions: 13 case reports
Reactions Weekly, 2013, 1477 (1) : 6 - 6
[3] Adalimumab/infliximabPsoriasiform reaction and dermatological reaction: 2 case reports
Reactions Weekly, 2018, 1697 (1) : 18 - 18
[4] Adalimumab/infliximabPsoriasiform eruptions with inflammatory alopecia: 5 case reports
Reactions Weekly, 2013, 1441 (1) : 5 - 5
[5] Adalimumab/infliximabPsoriasiform reaction and dermatological reaction: 3 case reports
Reactions Weekly, 2018, 1718 (1) : 15 - 15
[6] Adalimumab/infliximabPsoriasiform eruption: case report
Reactions Weekly, 2010, 1300 (1) : 5 - 5
[7] Adalimumab/infliximabPsoriasiform paradox skin reaction, influenza and lack of efficacy: 3 case reports
Reactions Weekly, 2021, 1863 (1) : 19 - 19
[8] Adalimumab/etanerceptCancer: 8 case reports
Reactions Weekly, 2010, 1311 (1) : 7 - 7
[9] Adalimumab/infliximabTuberculosis: 8 case reports
Reactions Weekly, 2019, 1740 (1) : 17 - 17
[10] Adalimumab/infliximabPsoriasis: 8 case reports
Reactions Weekly, 2008, 1183 (1) : 5 - 5

← 1 2 3 4 5 →